Steward Partners Investment Advisory’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.09K Hold
553
﹤0.01% 3684
2025
Q4
$4.97K Sell
553
-89
-14% -$1.23K ﹤0.01% 3694
2025
Q3
$11.1K Sell
642
-125
-16% -$1.54K ﹤0.01% 3359
2025
Q2
$7.2K Buy
767
+290
+61% +$2.38K ﹤0.01% 3347
2025
Q1
$3.39K Sell
477
-966
-67% -$9.76K ﹤0.01% 3499
2024
Q4
$16.8K Sell
1,443
-87
-6% -$1.36K ﹤0.01% 2877
2024
Q3
$31.4K Sell
1,530
-814
-35% -$18.8K ﹤0.01% 2457
2024
Q2
$52.5K Buy
2,344
+266
+13% +$6.33K ﹤0.01% 2081
2024
Q1
$57.2K Buy
2,078
+74
+4% +$2.06K ﹤0.01% 2039
2023
Q4
$61.1K Sell
2,004
-363
-15% -$10.4K ﹤0.01% 1895
2023
Q3
$74.8K Sell
2,367
-630
-21% -$24.4K ﹤0.01% 1716
2023
Q2
$122K Buy
2,997
+311
+12% +$12.6K ﹤0.01% 1488
2023
Q1
$100K Buy
2,686
+590
+28% +$23.1K ﹤0.01% 1592
2022
Q4
$73.1K Sell
2,096
-290
-12% -$13.8K ﹤0.01% 1679
2022
Q3
$134K Buy
2,386
+18
+0.8% +$1.12K ﹤0.01% 1374
2022
Q2
$123K Buy
2,368
+220
+10% +$11.2K ﹤0.01% 1418
2022
Q1
$156K Buy
2,148
+405
+23% +$34.3K ﹤0.01% 1389
2021
Q4
$206K Sell
1,743
-29
-2% -$3.63K ﹤0.01% 1302
2021
Q3
$238K Sell
1,772
-62
-3% -$9.39K ﹤0.01% 1205
2021
Q2
$297K Buy
1,834
+406
+28% +$31.6K 0.01% 1193
2021
Q1
$115K Buy
1,428
+1,131
+381% +$75.9K ﹤0.01% 1551
2020
Q4
$16K Buy
+297
New +$10.8K ﹤0.01% 2137
2020
Q2
Sell
-400
Closed -$4K 2718
2020
Q1
$4K Sell
400
-500
-56% -$6.74K ﹤0.01% 2153
2019
Q4
$13K Hold
900
﹤0.01% 1921
2019
Q3
$12K Buy
900
+500
+125% +$7.97K ﹤0.01% 1917
2019
Q2
$6K Buy
+400
New +$6.29K ﹤0.01% 2164
2018
Q4
Sell
-400
Closed -$11K 1675
2018
Q3
$11K Buy
+400
New +$11.6K ﹤0.01% 1842

Other funds holding NTLA